About the Study : In this multisite cohort of 346 adults receiving Oregon's state-regulated psilocybin services, serious adverse reactions were uncommon, and most participants reported improvements in depression, anxiety, PTSD symptoms, well-being, and life satisfaction. The longitudinal findings suggest that Oregon’s regulated psilocybin services were generally safe and associated with improved mental health outcomes.
Meeting Information
This paper is being presented at the Oregon Psychedelic Innovation Summit.
Corresponding Author : P. Todd Korthuis, MD, MPH, Oregon Health. Please send interview requests to Erik Robinson, Senior Communications Specialist, Oregon Health & Science University ( robineri@ohsu.edu ; 503-494-7986).
10.1001/jamanetworkopen.2026.30608
To access the embargoed study: Visit our JAMA Network Media Center at this link https://media.jamanetwork.com/
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Editor's Note : Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
JAMA Network Open